Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 26 studies | 41% ± 18% | |
fibroblast | 20 studies | 36% ± 18% | |
astrocyte | 19 studies | 68% ± 21% | |
oligodendrocyte | 15 studies | 47% ± 17% | |
oligodendrocyte precursor cell | 15 studies | 59% ± 21% | |
smooth muscle cell | 14 studies | 35% ± 16% | |
microglial cell | 14 studies | 46% ± 14% | |
pericyte | 13 studies | 36% ± 18% | |
glutamatergic neuron | 12 studies | 74% ± 21% | |
macrophage | 12 studies | 35% ± 15% | |
GABAergic neuron | 11 studies | 72% ± 21% | |
B cell | 10 studies | 28% ± 9% | |
epithelial cell | 10 studies | 43% ± 22% | |
adipocyte | 9 studies | 65% ± 14% | |
amacrine cell | 8 studies | 54% ± 21% | |
mast cell | 8 studies | 27% ± 11% | |
ciliated cell | 8 studies | 31% ± 15% | |
neuron | 7 studies | 55% ± 21% | |
retinal ganglion cell | 7 studies | 63% ± 27% | |
basal cell | 7 studies | 40% ± 22% | |
endothelial cell of lymphatic vessel | 7 studies | 34% ± 15% | |
type I pneumocyte | 7 studies | 37% ± 14% | |
T cell | 6 studies | 26% ± 9% | |
mesothelial cell | 6 studies | 37% ± 19% | |
interneuron | 6 studies | 79% ± 18% | |
myeloid cell | 6 studies | 27% ± 7% | |
retina horizontal cell | 6 studies | 68% ± 17% | |
retinal cone cell | 6 studies | 40% ± 14% | |
dendritic cell | 6 studies | 26% ± 6% | |
Mueller cell | 6 studies | 49% ± 20% | |
type II pneumocyte | 6 studies | 32% ± 12% | |
natural killer cell | 5 studies | 24% ± 7% | |
hepatocyte | 5 studies | 55% ± 34% | |
CD4-positive, alpha-beta T cell | 5 studies | 23% ± 4% | |
capillary endothelial cell | 5 studies | 25% ± 8% | |
retinal bipolar neuron | 5 studies | 36% ± 14% | |
cardiac muscle cell | 5 studies | 59% ± 18% | |
monocyte | 5 studies | 31% ± 8% | |
goblet cell | 5 studies | 30% ± 20% | |
club cell | 5 studies | 34% ± 12% | |
naive B cell | 4 studies | 17% ± 1% | |
effector memory CD8-positive, alpha-beta T cell | 4 studies | 24% ± 5% | |
abnormal cell | 4 studies | 34% ± 22% | |
glial cell | 4 studies | 39% ± 9% | |
granule cell | 4 studies | 69% ± 14% | |
myofibroblast cell | 4 studies | 35% ± 17% | |
plasma cell | 4 studies | 37% ± 7% | |
retinal pigment epithelial cell | 4 studies | 62% ± 22% | |
CD8-positive, alpha-beta T cell | 4 studies | 22% ± 3% | |
endothelial cell of artery | 4 studies | 17% ± 2% | |
OFF-bipolar cell | 4 studies | 55% ± 25% | |
ON-bipolar cell | 4 studies | 58% ± 23% | |
retinal rod cell | 4 studies | 41% ± 8% | |
respiratory goblet cell | 4 studies | 34% ± 17% | |
endothelial cell of vascular tree | 4 studies | 28% ± 12% | |
connective tissue cell | 4 studies | 29% ± 13% | |
naive thymus-derived CD4-positive, alpha-beta T cell | 3 studies | 24% ± 6% | |
hematopoietic precursor cell | 3 studies | 19% ± 3% | |
non-classical monocyte | 3 studies | 21% ± 6% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 51% ± 3% | |
GABAergic interneuron | 3 studies | 83% ± 11% | |
progenitor cell | 3 studies | 45% ± 8% | |
vein endothelial cell | 3 studies | 33% ± 13% | |
lymphocyte | 3 studies | 33% ± 5% | |
GABAergic amacrine cell | 3 studies | 78% ± 12% | |
glycinergic amacrine cell | 3 studies | 61% ± 2% | |
rod bipolar cell | 3 studies | 52% ± 18% | |
ependymal cell | 3 studies | 78% ± 2% | |
enteroendocrine cell | 3 studies | 26% ± 6% | |
leukocyte | 3 studies | 34% ± 13% | |
alveolar macrophage | 3 studies | 37% ± 12% | |
regulatory T cell | 3 studies | 21% ± 5% | |
muscle cell | 3 studies | 43% ± 34% | |
transit amplifying cell | 3 studies | 43% ± 36% | |
brush cell | 3 studies | 22% ± 5% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 42% ± 20% | |
mucus secreting cell | 3 studies | 38% ± 12% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 59% ± 23% | |
lung | 8 studies | 25% ± 11% | |
eye | 8 studies | 43% ± 18% | |
liver | 5 studies | 36% ± 21% | |
heart | 4 studies | 46% ± 12% | |
peripheral blood | 3 studies | 25% ± 5% | |
intestine | 3 studies | 20% ± 3% | |
adipose | 3 studies | 54% ± 19% | |
kidney | 3 studies | 50% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 9017.31 | 258 / 258 | 100% | 17.13 | 230 / 230 |
esophagus | 100% | 6501.20 | 1445 / 1445 | 100% | 18.95 | 183 / 183 |
prostate | 100% | 7903.26 | 245 / 245 | 100% | 13.46 | 502 / 502 |
breast | 100% | 6622.79 | 459 / 459 | 100% | 19.48 | 1117 / 1118 |
brain | 100% | 6192.43 | 2634 / 2642 | 100% | 22.60 | 704 / 705 |
uterus | 100% | 9515.88 | 170 / 170 | 99% | 14.39 | 456 / 459 |
thymus | 100% | 8064.82 | 653 / 653 | 99% | 14.70 | 601 / 605 |
kidney | 100% | 5162.57 | 89 / 89 | 99% | 16.32 | 894 / 901 |
bladder | 100% | 5968.71 | 21 / 21 | 99% | 13.13 | 500 / 504 |
ovary | 100% | 8973.77 | 180 / 180 | 99% | 13.72 | 426 / 430 |
intestine | 100% | 7151.73 | 966 / 966 | 99% | 11.52 | 522 / 527 |
pancreas | 100% | 4670.43 | 328 / 328 | 99% | 13.87 | 176 / 178 |
lung | 100% | 5717.33 | 578 / 578 | 99% | 14.68 | 1142 / 1155 |
skin | 100% | 7074.80 | 1809 / 1809 | 99% | 14.63 | 465 / 472 |
stomach | 100% | 5197.35 | 359 / 359 | 98% | 13.55 | 281 / 286 |
liver | 100% | 4454.14 | 226 / 226 | 94% | 8.75 | 380 / 406 |
adipose | 100% | 6760.37 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 12.70 | 29 / 29 |
spleen | 100% | 6277.82 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 7.12 | 1 / 1 |
blood vessel | 100% | 7415.82 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 4285.60 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 4016.96 | 848 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 12.24 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 90% | 9.36 | 72 / 80 |
peripheral blood | 40% | 1463.05 | 374 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0035195 | Biological process | miRNA-mediated post-transcriptional gene silencing |
GO_0007492 | Biological process | endoderm development |
GO_0033962 | Biological process | P-body assembly |
GO_0009267 | Biological process | cellular response to starvation |
GO_0035278 | Biological process | miRNA-mediated gene silencing by inhibition of translation |
GO_0060213 | Biological process | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening |
GO_0000932 | Cellular component | P-body |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0016442 | Cellular component | RISC complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0030674 | Molecular function | protein-macromolecule adaptor activity |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | TNRC6A |
Protein name | Trinucleotide repeat-containing gene 6A protein (CAG repeat protein 26) (EMSY interactor protein) (GW182 autoantigen) (Protein GW1) (Glycine-tryptophan protein of 182 kDa) Trinucleotide repeat containing adaptor 6A |
Synonyms | CAGH26 TNRC6 KIAA1460 |
Description | FUNCTION: Plays a role in RNA-mediated gene silencing by both micro-RNAs (miRNAs) and short interfering RNAs (siRNAs). Required for miRNA-dependent repression of translation and for siRNA-dependent endonucleolytic cleavage of complementary mRNAs by argonaute family proteins. As a scaffolding protein, associates with argonaute proteins bound to partially complementary mRNAs, and can simultaneously recruit CCR4-NOT and PAN deadenylase complexes. . |
Accessions | H7C269 ENST00000395799.8 [Q8NDV7-1] ENST00000568750.1 I3L3S5 I3L218 H3BRT3 ENST00000315183.11 [Q8NDV7-6] ENST00000491718.5 ENST00000450465.6 H3BTQ1 Q8NDV7 ENST00000569098.1 ENST00000569376.5 |